• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Quantitative proteomic approach identifies Vpr binding protein as novel host factor supporting influenza A virus infections in human c

tetano

Editor, Senior Moderator
Sign in to NCBI

[h=1]PubMed[/h] US National Library of Medicine National Institutes of Health

Search database





Search term



[h=2]Result Filters[/h]
[h=4]Send to[/h]





Mol Cell Proteomics. 2017 Mar 13. pii: mcp.M116.065904. doi: 10.1074/mcp.M116.065904. [Epub ahead of print]
[h=1]Quantitative proteomic approach identifies Vpr binding protein as novel host factor supporting influenza A virus infections in human cells.[/h] Sadewasser A[SUP]1[/SUP], Paki K[SUP]1[/SUP], Eichelbaum K[SUP]2[/SUP], Bogdanow B[SUP]2[/SUP], Saenger S[SUP]1[/SUP], Budt M[SUP]1[/SUP], Lesch M[SUP]3[/SUP], Hinz KP[SUP]4[/SUP], Herrmann A[SUP]5[/SUP], Meyer TF[SUP]3[/SUP], Karlas A[SUP]3[/SUP], Selbach M[SUP]2[/SUP], Wolff T[SUP]6[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Influenza A virus infections are a major cause for respiratory disease in humans, which affects all age groups and contributes substantially to global morbidity and mortality. IAV have a large natural host reservoir in avian species. However, many avian IAV strains lack adaptation to other hosts and hardly propagate in humans. While seasonal or pandemic influenza A virus (IAV) strains replicate efficiently in permissive human cells, many avian IAV cause abortive non-productive infections in these hosts despite successful cell entry. However, the precise reasons for these differential outcomes are poorly defined. We hypothesized that the distinct course of an IAV infection with a given virus strain is determined by the differential interplay between specific host and viral factors. By using Spike-in SILAC mass spectrometry-based quantitative proteomics we characterized sets of cellular factors whose abundance is specifically up- or down-regulated in the course of permissive vs. non-permissive IAV infection, respectively. This approach allowed for the definition and quantitative comparison of about 3500 proteins in human lung epithelial cells in response to seasonal or low-pathogenic avian H3N2 IAV. Many identified proteins were similarly regulated by both virus strains, but also 16 candidates with distinct changes in permissive vs. non-permissive infection were found. RNAi-mediated knockdown of these differentially regulated host factors identified Vpr binding protein (VprBP) as pro-viral host factor since its down-regulation inhibited efficient propagation of seasonal IAV while over-expression increased viral replication of both seasonal and avian IAV. These results not only show that there are similar differences in the overall changes during permissive and non-permissive imfluenza virus infections, but also provide a basis to evaluate VprBP as novel anti-IAV drug target.
Copyright ? 2017, The American Society for Biochemistry and Molecular Biology.


[h=4]KEYWORDS:[/h] Infectious disease; Influenza A virus; SILAC; Systems biology*; Viruses; VprBP; siRNA*

PMID: 28289176 DOI: 10.1074/mcp.M116.065904
Free full text
 
Back
Top